Skip to main content
. 2021 Jul 7;13:11795735211029114. doi: 10.1177/11795735211029114

Table 1.

Demographic, comorbidity distribution, and salivary total protein between study groups and their relation to salivary HO-1.

Groups Non-neurological Control Degenerative neurological Control Non-degenerative neurological Control PD All non-neurodegenerative Control All neurodegenerative condition P value
N 162 37 33 75 195 112
Protein (mean (SD)) (mg/ml) 2.81 (1.39) 3.39 (1.61) 3.31 (1.34) 3.99 (1.98) 2.9 (1.39) 3.79 (1.88) <.01
Age (mean(SD)) 62.19 (12) 80.14 (6) 60.7 (14) 72.65 (11) 62 (12) 75 (10) <.01
Female (%) 99 (61%) 21 (57%) 24 (73%) 18 (24%) 99 (51%) 39 (35%) <.01
Male (%) 63 (39%) 16 (43%) 9 (27%) 57 (76%) 63 (32%) 73 (65%)
Arthritis (%) 43 (27%) 12 (32%) 10 (27%) 30 (40%) 53 (27%) 42 (38%) .08
No arthritis (%) 119 (74%) 25 (68%) 23 (73%) 45 (60%) 142 (73%) 70 (63%)
Thyroid condition (%) 29 (18%) 4 (11%) 10 (30%) 16 (21%) 39 (20%) 20 (18%) .76
No-thyroid condition (%) 133 (82%) 33 (89%) 23 (70%) 59 (79%) 156 (80%) 92 (82%)
Cardiac condition (%) 9 (6%) 9 (24%) 3 (9%) 12 (16%) 12 (6%) 21 (19%) <.01
No-cardiac condition (%) 153 (94%) 28 (76%) 30 (91%) 63 (84%) 183 (94%) 91 (81%)
Diabetes (%) 19 (12%) 6 (16%) 3 (9%) 4 (5%) 22 (11%) 10 (9%) .65
No diabetes (%) 143 (88%) 31 (84%) 30 (91%) 71 (95%) 173 (89%) 102 (91%)